Canada Pension Plan Investment Board
PBYI icon

Canada Pension Plan Investment Board’s Puma Biotechnology PBYI Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
73,500
+50,700
+222% +$371K ﹤0.01% 1200
2026
Q1 		$146K Sell
22,800
-52,400
-70% -$338K ﹤0.01% 1618
2025
Q4 		$447K Buy
+75,200
New +$399K ﹤0.01% 1340
2019
Q3 		– Sell
-23,113
Closed -$294K – 1262
2019
Q2 		$294K Sell
23,113
-3,099
-12% -$71.4K ﹤0.01% 1111
2019
Q1 		$1.02M Sell
26,212
-25,788
-50% -$788K ﹤0.01% 1107
2018
Q4 		$1.06M Buy
52,000
+14,300
+38% +$429K ﹤0.01% 1075
2018
Q3 		$1.73M Buy
+37,700
New +$1.82M ﹤0.01% 1038
2018
Q2 		– Sell
-38,100
Closed -$2.59M – 1279
2018
Q1 		$2.59M Buy
38,100
+3,000
+9% +$225K ﹤0.01% 930
2017
Q4 		$3.47M Buy
35,100
+15,800
+82% +$1.77M 0.01% 775
2017
Q3 		$2.31M Sell
19,300
-23,600
-55% -$2.2M ﹤0.01% 819
2017
Q2 		$3.75M Sell
42,900
-100
-0.2% -$5.59K 0.01% 709
2017
Q1 		$1.6M Buy
43,000
+21,700
+102% +$792K ﹤0.01% 839
2016
Q4 		$654K Buy
21,300
+4,600
+28% +$199K ﹤0.01% 824
2016
Q3 		$1.12M Buy
16,700
+5,800
+53% +$293K ﹤0.01% 779
2016
Q2 		$325K Buy
10,900
+4,200
+63% +$131K ﹤0.01% 923
2016
Q1 		$197K Buy
6,700
+2,800
+72% +$127K ﹤0.01% 998
2015
Q4 		$306K Buy
3,900
+2,100
+117% +$165K ﹤0.01% 974
2015
Q3 		$136K Sell
1,800
-1,200
-40% -$113K ﹤0.01% 1083
2015
Q2 		$350K Sell
3,000
-900
-23% -$163K ﹤0.01% 984
2015
Q1 		$921K Buy
+3,900
New +$834K ﹤0.01% 861

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's PBYI Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Puma Biotechnology (PBYI) stake by 222% in Q2 2026, buying an estimated $371K and bringing the position to 73,500 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Canada Pension Plan Investment Board first reported a position in PBYI in Q1 2015 and has held it in 20 quarters since. The position peaked at $3.75M in Q2 2017. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Canada Pension Plan Investment Board held 73,500 shares of Puma Biotechnology worth $596K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 50,700 Puma Biotechnology shares in Q2 2026, an estimated $371K.
  • Puma Biotechnology made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1200 holding.
  • Canada Pension Plan Investment Board first reported a position in Puma Biotechnology in Q1 2015 and has held it in 20 quarters since.
  • Canada Pension Plan Investment Board's Puma Biotechnology position peaked at $3.75M in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.